Amylin, Tripos, MDS-Panlabs Inc. deal

AMLN acquired access to 100,000 compounds from the Optiverse small

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE